US equities |
MU $684.73 ▲+4.32% NVDA $186.11 ▲+2.48% AMD $436.69 ▲+7.99% SNDK $826.49 ▲+2.49% SPCX $131.23 ▲+6.16% TSLA $358.09 ▲+4.19% AAPL $343.83 ▼-0.10% MSFT $533.39 ▼-0.47%
FinancialContent

Profound Medical Corp. - common stock (NQ:PROF)

6.930 +0.050 (+0.73%)
Delayed Quote Updated: 12:56 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Profound Medical Corp. - common stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Securities Fraud Investigation Into Profound Medical Corp. (PROF) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 6, 2025 ↗
 
Via Benzinga
News headline image
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Proposed Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’
TULSA procedure’s unrivaled flexibility, real-world efficacy and ongoing CAPTAIN post-market study to be featured in the scientific programs at the upcoming RSNA and SUO meetings 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Participate in the Stifel 2024 Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Third Quarter 2024 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer
From Profound Medical Corp.
Via GlobeNewswire
News headline image
iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024
Via ACCESSWIRE
News headline image
Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
From Profound Medical Corp.
Via GlobeNewswire
News headline image
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024 ↗
PROF stock results show that Profound Medical beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Profound Medical Announces Second Quarter 2024 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Annual General Meeting of Shareholders Voting Results
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
From Profound Medical Corp.
Via GlobeNewswire
News headline image
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024 ↗
PROF stock results show that Profound Medical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
From Profound Medical Corp.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >